Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Trial Name: A Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer.
Protocol ID: RTOG 1016
No prior cetuximab or other anti-EGFR therapy.
Enrollment: • About 706 people will take part in this study at several medical centers.
Taking part in this study may or may not make your health better. While doctors hope radiation therapy with cetuximab will be as effective in keeping your head and neck cancer from growing as radiation therapy and cisplatin with less severe side effects, there is no proof of this yet. The effects of a combination of radiation and cetuximab may be no different or worse than radiation and cisplatin. We do know that the information from this study will help doctors learn more about these therapies as a treatment for head and neck cancer that is HPV positive. This information could help future cancer patients.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Aspirus Regional Cancer Center Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353, or Langlade Cancer Center Research Nurse Debra Witman @ 715-623-9587.
Created: Dec 1, 2011
Updated: May 21, 2014